Finance

Lists
Why is PRE down ८.११%?
Dive Deeper
PRE:NASDAQ
Prenetics Global Ltd
US$ २०.१७
-८.११%
(-१.७८) 1D
US$ २०.१७
०.००% (०.००)
After hours
Closed: अक्टोबर २, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
US$ २२.१५
High
US$ २२.२२
Low
US$ १९.८५
Mkt. cap
३४.५८ करोड
Avg. vol.
२.४९ लाख
Volume
३.१२ लाख
52-wk high
US$ २७.२४
52-wk low
US$ ११.३६
EPS
-US$ २.८८
Beta
०.४०
Shares outstanding
१.५६ करोड
No. of employees
९८
Open
US$ २२.१५
High
US$ २२.२२
Low
US$ १९.८५
Mkt. cap
३४.५८ करोड
Avg. vol.
२.४९ लाख
Volume
३.१२ लाख
52-wk high
US$ २७.२४
52-wk low
US$ ११.३६
EPS
-US$ २.८८
Beta
०.४०
Shares outstanding
१.५६ करोड
No. of employees
९८
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees९८
Founded२०१४
Headquarters-
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current US$ २०.१७
US$ ४०.०० (+९८.३१%)
Average
US$ ३७.०० (+८३.४४%)
Lowest
US$ ३५.०० (+७३.५३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Des Lauriers
Craig-Hallum
Buy
Maintained
-
-
09/22/2026
Unknown Analyst
StoneX
Buy
Reiterated
US$ ४०.००
+९८.३%
09/08/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
US$ ३७.००
+८३.४%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
US$ ३५.००
+७३.५%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
US$ ३६.००
+७८.५%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
US$ ४०.००
+९८.३%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-३१.४५%
-२०.५२%
-६४.२६%
-१९.३२%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू